• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

LBO France's Gioconda backs Demas

  • Alessia Argentieri
  • Alessia Argentieri
  • 15 May 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

LBO France, via its Italian division Gioconda, has acquired a majority stake in Demas, an Italian distributor of veterinary products.

The investment was made via the Small Caps Opportunities fund, which held a final close on €104m in November 2018 and has a dedicated investment team of six managers, three of whom are based in Milan.

The fund invests in high-growth French and Italian companies with strong potential for international expansion and an enterprise value of less than €100m.

Demas

  • DEAL:

    Buyout

  • LOCATION:

    Rome

  • SECTOR:

    Speciality retailers

  • FOUNDED:

    1969

  • TURNOVER:

    €126m (2019)

  • STAFF:

    160

This is the eighth investment made by the fund and its third deal in Italy, following the acquisition of glass packaging manufacturer Vetroelite in May 2017 and the purchase of Bluclad, a company specialising in metal galvanisation for the fashion and luxury industry, in December 2018.

Italian lender Banca IFIS and logistics company Giovanni Ambrosetti also took part in the investment, alongside the company's management team, led by chair Fabrizio Foglietti, who will stay on with the business and retain his role. The vendors – the founding Foglietti family – will retain a minority stake in the company.

A debt package to support the deal was provided by BPER Banca, Banco BPM and Intesa SanPaolo.

With the support of Gioconda, the company plans to boost its organic growth, expand its product range, and pursue a buy-and-build strategy through M&A in Italy and internationally.

Company
Established in 1969 and headquartered in Rome, Demas specialises in distributing veterinary and pet products.

The company supplies pharmacies across Italy with veterinary drugs, medicines and food supplements, and operates a subsidiary, Foschi, which provides vets and animal clinics with healthcare products, medication, equipment, medical devices and diagnostic tools.

In addition, Demas sells veterinary care products, pet food and accessories through its chain of retail stores named Giulius, based in Rome and its outskirts.

The company employs 160 staff and generates revenues of €126m.

People
Gioconda
– Arthur Bernardin (managing director).
Demas – Fabrizio Foglietti (CEO, chair).

Advisers
Equity
– Deloitte (financial due diligence); Goetz Partners (financial due diligence); KPMG (operational due diligence); NCTM Studio Legale (legal).
Company – De Vecchi (M&A); Orrick (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Southern Europe
  • Consumer
  • LBO France
  • Italy
  • KPMG
  • Orrick

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013